The Improved Experience You’ve Been Waiting For!
Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach.
Explore Now
BLACU
Bellevue Life Sciences Acquisition Corp. Unit
Bellevue Life Sciences Acquisition Corp. Unit (BLACU) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the Bellevue Life Sciences Acquisition Corp. Unit stock forecast from 0 analysts, the average analyst target price for Bellevue Life Sciences Acquisition Corp. Unit is not available over the next 12 months. Bellevue Life Sciences Acquisition Corp. Unit’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Bellevue Life Sciences Acquisition Corp. Unit is Very Bearish, which is based on 0 positive signals and 2 negative signals. At the last closing, Bellevue Life Sciences Acquisition Corp. Unit’s stock price was USD 11.14. Bellevue Life Sciences Acquisition Corp. Unit’s stock price has changed by +1.83% over the past week, +2.58% over the past month and +5.39% over the last year.
No recent analyst target price found for Bellevue Life Sciences Acquisition Corp. Unit
No recent average analyst rating found for Bellevue Life Sciences Acquisition Corp. Unit
Company Overview Bellevue Life Sciences Acquisition Corp. Unit
Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC. Read Less
Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the health...Read More
N/A
10900 NE 4th Street, Bellevue, WA, United States, 98004
0
December
USD
USA
Adjusted Closing Price for Bellevue Life Sciences Acquisition Corp. Unit (BLACU)
Loading...
Unadjusted Closing Price for Bellevue Life Sciences Acquisition Corp. Unit (BLACU)
Loading...
Share Trading Volume for Bellevue Life Sciences Acquisition Corp. Unit Shares
Loading...
Compare Performance of Bellevue Life Sciences Acquisition Corp. Unit Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for BLACU
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To Bellevue Life Sciences Acquisition Corp. Unit (Sector: Shell Companies )
Frequently Asked Questions About Bellevue Life Sciences Acquisition Corp. Unit (BLACU) Stock
Stock Target Advisor's fundamental analysis for Bellevue Life Sciences Acquisition Corp. Unit's stock is Very Bearish.
Unfortunately we do not have enough data on BLACU's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on BLACU's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on BLACU's stock to indicate if its overvalued.
The last closing price of BLACU's stock was USD 11.14.
Unfortunately we do not currently have any market capitalization data for BLACU's stock.
Unfortunately we do not have enough analyst data on BLACU's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Bellevue Life Sciences Acquisition Corp. Unit's stock.
As per our most recent records Bellevue Life Sciences Acquisition Corp. Unit has 0 Employees.
Bellevue Life Sciences Acquisition Corp. Unit's registered address is 10900 NE 4th Street, Bellevue, WA, United States, 98004.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BLACU !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
